Open Access

REVIEW

Pharmacologic stress cardiovascular magnetic resonance in the pediatric population: A review of the literature, proposed protocol, and two examples in patients with Kawasaki disease

Munes Fares¹, Paul J. Critser², Maria J. Arruda¹, Carolyn M. Wilhelm¹, Mantosh S. Rattan³, Sean M. Lang^2,4, Tarek Alsaied^2,4

1 Division of Pediatric Cardiology, UH Rainbow Babies & Children’s Hospital, Cleveland, Ohio
2 Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3 Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
4 Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio

* Corresponding Author: Tarek Alsaied, Faculty of Medicine, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati, MLC 2003, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. Email:

Congenital Heart Disease 2019, 14(6), 1166-1175. https://doi.org/10.1111/chd.12840

Abstract

Pharmacologic stress cardiovascular magnetic resonance (PSCMR) is a wellestablished and reliable diagnostic tool for evaluation of coronary artery disease in the adult population. Stress imaging overall and PSCMR in particular is less utilized in the pediatric population with limited reported data. In this review, we highlight the potential use of PSCMR in specific pediatric cohorts with congenital and acquired heart disease, and we review the reported experience. A suggested protocol is presented in addition to two case examples of patients with Kawasaki disease where PSCMR aided decision making.

---

Keywords

---